Total Payments
$140,029
2024 Payments
$42,172
Companies
14
Transactions
115
Payment Breakdown by Category
Consulting$95,586 (68.3%)
Travel$30,277 (21.6%)
Other$10,742 (7.7%)
Food & Beverage$3,412 (2.4%)
Education$12.70 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $95,586 | 28 | 68.3% |
| Travel and Lodging | $30,277 | 35 | 21.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,742 | 4 | 7.7% |
| Food and Beverage | $3,412 | 47 | 2.4% |
| Education | $12.70 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $62,223 | 50 | $0 (2024) |
| AstraZeneca UK Limited | $21,837 | 13 | $0 (2023) |
| F. Hoffmann-La Roche AG | $18,437 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $12,383 | 14 | $0 (2024) |
| Genentech, Inc. | $7,115 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $6,536 | 6 | $0 (2024) |
| Genentech USA, Inc. | $6,270 | 2 | $0 (2024) |
| Midmark Corporation | $4,276 | 4 | $0 (2019) |
| Mylan Specialty L.P. | $451.97 | 7 | $0 (2024) |
| Monaghan Medical Corporation | $150.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42,172 | 24 | F. Hoffmann-La Roche AG ($18,437) |
| 2023 | $33,259 | 28 | AstraZeneca Pharmaceuticals LP ($29,058) |
| 2022 | $27,574 | 17 | AstraZeneca UK Limited ($18,738) |
| 2021 | $3,759 | 1 | AstraZeneca Pharmaceuticals LP ($3,759) |
| 2020 | $12.70 | 1 | Merck Sharp & Dohme Corporation ($12.70) |
| 2019 | $4,560 | 8 | Midmark Corporation ($4,276) |
| 2018 | $49.00 | 1 | Mylan Specialty L.P. ($49.00) |
| 2017 | $28,643 | 35 | AstraZeneca Pharmaceuticals LP ($23,896) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $660.00 | General |
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,340.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $118.08 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $105.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,801.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $106.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $100.14 | General |
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $40.69 | General |
| 09/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $68.19 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/08/2024 | F. Hoffmann-La Roche AG | — | Travel and Lodging | Cash or cash equivalent | $9,188.47 | General |
| 07/08/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $7,590.00 | General |
| 07/08/2024 | F. Hoffmann-La Roche AG | — | Travel and Lodging | Cash or cash equivalent | $567.14 | General |
| 07/08/2024 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $204.30 | General |
| 07/08/2024 | F. Hoffmann-La Roche AG | — | Travel and Lodging | Cash or cash equivalent | $139.55 | General |
| 07/08/2024 | F. Hoffmann-La Roche AG | — | Travel and Lodging | Cash or cash equivalent | $87.07 | General |
| 07/01/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,970.00 | General |
| 05/23/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,525.00 | General |
| 05/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $45.48 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $731.67 | General |
| 05/13/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $233.90 | General |
| 03/13/2024 | Genentech, Inc. | Xolair (Biological) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: Immunology | ||||||
| 11/12/2023 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,640.00 | General |
About Dr. David Mannino, MD
Dr. David Mannino, MD is a Internal Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982628889.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Mannino, MD has received a total of $140,029 in payments from pharmaceutical and medical device companies, with $42,172 received in 2024. These payments were reported across 115 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($95,586).
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Lexington, KY
- Active Since 07/26/2006
- Last Updated 03/16/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982628889
Products in Payments
- BREZTRI (Drug) $17,721
- DUPIXENT (Biological) $6,536
- Xolair (Biological) $4,200
- AIRSUPRA (Drug) $1,936
- YUPELRI (Drug) $402.97
- Aerobika (Device) $150.00
- ALVESCO (Drug) $77.86
- UTIBRON (Drug) $46.47
- OFEV (Drug) $34.43
- ZERBAXA (Drug) $12.70
- TRELEGY ELLIPTA (Drug) $11.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lexington
Dr. Firas Badin, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Dennis Doherty, Md, MD
Internal Medicine — Payments: $686,622
Internal Medicine $686,622
Dr. Robert Sawyer, M.d, M.D
Internal Medicine — Payments: $232,104
Internal Medicine $232,104
Dr. Anastasia Jandes, Md, MD
Internal Medicine — Payments: $90,742
Internal Medicine $90,742
Gloria Vigliani, M.d, M.D
Internal Medicine — Payments: $89,452
Internal Medicine $89,452
David Moliterno, Md, MD
Internal Medicine — Payments: $76,038
Internal Medicine $76,038